Celsius vs. Colgate-Palmolive: Which Consumer Goods Stock Is a Better Buy for 2027?

Should I buy the high-octane growth of Celsius (NASDAQ:CELH) or the steady, defensive reliability of Colgate-Palmolive (NYSE:CL)? Both companies command strong brand loyalty but serve very different investor goals.

Celsius specializes in functional energy drinks that appeal to health-conscious consumers, while Colgate-Palmolive is a global giant in household essentials like toothpaste and pet food. While one seeks to disrupt the beverage aisle, the other relies on decades of market dominance. This comparison examines whether growth or stability is the better play for 2027.

The case for Celsius

Celsius offers functional beverages designed for active lifestyles, marketing its products as healthier alternatives to traditional energy drinks. In its latest annual report, sales to Pepsi constituted nearly 43.2% of total net revenue, and customer concentration like this adds a layer of risk to the business. The company remains a high-growth standout among beverage stocks as it scales the Alani Nu and Rockstar brands.

In the 12 months ended Sept. 30, 2026, revenue reached nearly $3.2 billion. This represents revenue growth of approximately 49.1% compared to the prior period, driven by expanded retail shelf space and consumer demand. Net income for the same timeframe was close to $235 million, which represents a significant increase as the company leverages its distribution agreement with Pepsi.

As of its December 2025 balance sheet, the debt-to-equity ratio is roughly 0.2x. This ratio measures total debt against shareholder equity, where a lower number indicates a conservative capital structure with little reliance on debt. The current ratio, which compares short-term assets to liabilities, is approximately 1.7x. In the fiscal year ended Dec. 31, 2025, free cash flow reached nearly $323.4 million.

The case for Colgate-Palmolive

Colgate-Palmolive is a titan in the consumer staples space, operating across oral care, personal hygiene, and pet nutrition segments. In its latest annual report, Walmart (NASDAQ:WMT) and its affiliates accounted for approximately 11% of net sales. Customer concentration like this adds a layer of risk to the business, though the company maintains a massive global footprint under brands like Hill's Science Diet.

In the 12 months ended Sept. 30, 2026, revenue reached close to $21.3 billion. This reflects revenue growth of roughly 5.9% as the company navigated varying economic conditions across its international markets. Net income for the period was approximately $2.1 billion, and the company maintained a net margin of nearly 9.6% while continuing to invest in its productivity programs.

As of its December 2025 balance sheet, the debt-to-equity ratio was roughly 158.4x. This metric compares total debt to the value of shareholder equity, reflecting the capital structure the company uses to fund its global operations. The current ratio, which assesses the ability to meet short-term debts, stands at approximately 0.8x. In the fiscal year ended Dec. 31, 2025, free cash flow was nearly $3.6 billion.

Risk profile comparison

Celsius faces risk from its heavy reliance on Pepsi for distribution, as any disagreement could materially disrupt its financial results. The company also operates a co-packer-dependent manufacturing model, exposing it to supply chain disruptions or quality issues. Additionally, it faces intense pressure from well-funded rivals like Monster Beverage (NASDAQ:MNST) and The Coca-Cola Company (NYSE:KO).

Colgate-Palmolive manages significant global operations that expose it to foreign currency fluctuations and geopolitical instability across diverse markets. It must consistently innovate to compete with both private labels and multinational peers like Procter & Gamble (NYSE:PG). Furthermore, the company faces potential legal liability from product-related litigation, including claims related to talc ingredients, which could impact its long-term financial health.

Valuation comparison

Celsius trades at a lower P/S ratio, measuring market value against sales over the past twelve months, than the more established Colgate-Palmolive.

Valuation metrics include sourcing from Financial Modeling Prep (FMP) and may differ from other data providers.

To understand these figures, note that the Forward P/E ratio compares the stock price to future earnings estimates per share.

Which stock would I buy for 2027?

I'd go with Colgate-Palmolive. It has raised its dividend for 63 straight years and holds the biggest share of the world's toothpaste market, which gives it a dependable base to build on. Its Hill's pet food business, now almost a quarter of sales, adds a second source of growth.

The company continues to pour money into its brands, with advertising up double digits again last quarter, and sales grew in all four of its product categories. Costs are rising and U.S. shoppers are cautious, but those pressures are hitting the whole industry, and the rest of Colgate's business is still growing.

To give Celsius its due, its Alani Nu brand has become a hit, and PepsiCo's delivery network is helping it reach more stores. But sales of its namesake Celsius brand are shrinking, and much of its recent growth came from buying other brands.

For investors who plan to hold for years, Colgate combines steady growth with a growing dividend and products people buy in any economy, making it a smart pick for 2027.

Sara Appino has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Colgate-Palmolive, Monster Beverage, and Walmart. The Motley Fool recommends Celsius Holdings. The Motley Fool has a disclosure policy.